Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.
|
|
For the Three Months
Ended September 30,
|
|
|
For the Nine Months
Ended September 30,
|
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
Financing Warrant to purchase common stock
|
|
-
|
|
|
|
13,889
|
|
|
-
|
|
|
|
13,889
|
|
IPO Warrants to purchase common stock
|
|
|
-
|
|
|
|
11,600
|
|
|
|
-
|
|
|
|
11,600
|
|
Warrant issued to private investors
|
|
|
3,035,688
|
|
|
|
3,035,688
|
|
|
|
3,035,688
|
|
|
|
3,035,688
|
|
Options to purchase common stock
|
|
|
656,494
|
|
|
|
1,149,589
|
|
|
|
656,494
|
|
|
|
1,149,589
|
|
RSUs
|
|
|
2,276,996
|
|
|
|
2,498,037
|
|
|
|
2,276,996
|
|
|
|
2,498,037
|
|
PSUs
|
|
|
871,559
|
|
|
|
1,153,617
|
|
|
|
871,559
|
|
|
|
1,153,617
|
|
Total potentially dilutive securities
|
|
|
6,840,737
|
|
|
|
7,862,420
|
|
|
|
6,840,737
|
|
|
|
7,862,420
|
|
|